Iloprost in COVID-19: The Rationale of Therapeutic Benefit.

Faggioli, Paola Maria; Mumoli, Nicola; Mazzone, Antonino

Faggioli, Paola Maria; Mumoli, Nicola; Mazzone, Antonino.

Afiliación

Faggioli PM; Internal Medicine Azienda Socio Sanitaria Territoriale OVEST Milanese, Legnano Hospital, Milan, Italy.
Mumoli N; Internal Medicine Azienda Socio Sanitaria Territoriale OVEST Milanese, Magenta Hospital, Milan, Italy.
Mazzone A; Internal Medicine Azienda Socio Sanitaria Territoriale OVEST Milanese, Legnano Hospital, Milan, Italy.

Front Cardiovasc Med ; 8: 649499, 2021.

Article en En | MEDLINE | ID: mdl-33969013

Palabras clave

COVID-19; iloprost; inflammation; therapy; thrombosis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Front Cardiovasc Med Año: 2021 Tipo del documento: Article País de afiliación: Italia